Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Clinical trial NCT04771572 · RECRUITING

Trial details

NCT number: NCT04771572
Sponsor: Newave Pharmaceutical Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma Richter Transformation Multiple Myeloma T-cell-prolymphocytic Leukemia Acute Myeloid Leukemia Acute Lymphocytic Leukemia Myeodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm Myelofibrosis Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Chronic Myelomonocytic Leukemia-2

Start date: 2022-05-08
Primary completion: 2026-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.